Search

Search Constraints

You searched for: Author/Creator Ross, Fiona M.

Search Results

1. A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma. Issue 2 (7th October 2014)

2. Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma. Issue 9 (September 2013)

4. Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results. (27th March 2014)

5. Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high‐dose therapy. (29th January 2013)